Nexavar Post-marketing Surveillance for RCC in Japan: Early Access Program

Clinical trial NCT01412671 · COMPLETED

Trial details

NCT number: NCT01412671
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Carcinoma, Renal Cell

Start date: 2008-02-27
Primary completion: 2011-09-21
Enrollment: 117

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.